Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients. Issue 9 (31st July 2021)

• Record Type: Journal Article
• Authors: Vutien, Philip; Perkins, James; Biggins, Scott W.; Reyes, Jorge; Imlay, Hannah; Limaye, Ajit P.
• Is Part Of: Liver transplantation. Volume 27:Issue 9(2021)
• Page Start: 1302
• Page End: 1311
• Publication Date: 2021-07-31
• Subjects: Liver -- Transplantation -- Periodicals; Liver -- Diseases -- Periodicals; Liver Transplantation -- Periodicals; Foie -- Greffe -- Périodiques; 617.5560592
• DOI: 10.1002/lt.26045
• Languages: English
• ISSNs: 1527-6465

Abstract

Abstract : Among solid organ transplant recipients, donor cytomegalovirus (CMV) seropositive (D+) and recipient seronegative (R−) status are associated with an increased risk of graft loss and mortality after kidney or lung transplantation. Whether a similar relationship exists among liver transplant recipients (LTR) is unknown. We assessed graft loss and mortality among adult LTRs from January 1, 2010, to March 14, 2020, in the Organ Procurement and Transplantation Network database. We used multivariable mixed Cox proportional hazards regression to analyze the association of donor and recipient CMV serostatus group with graft loss and mortality, with donor seronegative (D−) and recipient seronegative (R−) as the reference group. Among 54, 078 LTRs, the proportion of D−R−, D− and recipient seropositive (R+), D+R−, and D+R+ was 13.4%, 22.5%, 22%, and 42%, respectively. By unadjusted Kaplan‐Meier survival curve estimates, survival by the end of follow‐up was 73.3%, 73.5%, 70.1%, and 69.7%, among the D−R−, D−R+, D+R−, and D+R+ groups, respectively. By multivariable Cox regression, the CMV D+R− serogroup, but not other serogroups, was independently associated with increased risks of graft loss (adjusted hazard ratio [aHR], 1.13; 95% confidence interval [CI], 1.05‐1.22) and mortality (aHR, 1.13; 95% CI, 1.05‐1.22). The magnitude of the association of the CMV D+R− serostatus group with mortality was similar when the Cox regression analysis was restricted to the first year after transplant and beyond the first year after transplant: aHR, 1.13 (95% CI, 1.01‐1.27) and aHR, 1.13 (95% CI, 1.02‐1.25), respectively. Even in an era of CMV preventive strategies, CMV D+R− serogroup status remains independently associated with increased graft loss and mortality in adult LTRs. Factors in addition to direct CMV‐associated short‐term mortality are likely, and studies to define the underlying mechanism(s) are warranted.